Abstract
Cancer pain syndromes in the urogenital region may be related to diagnostic procedures, antineoplastic treatments, or tumors themselves. Evaluation of cancer pain, in general, is multidimensional, involving subjective and objective data, as well as giving attention to psychosocial and spiritual factors. Management of cancer pain requires a multimodal, multidisciplinary approach. Medications are the mainstay of cancer pain treatment, with nerve blocks and radiation being important considerations in a comprehensive pain plan.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ripamonti CI, Santini D, Maranzo E, et al. Management of cancer pain: ESMO clinical practice guidelines. Ann Oncol. 2012;23:139–54.
Cohen MZ, Easley MK, Ellis C, et al. Cancer pain management and the JCAHO’s pain standards: an institutional challenge. J Pain Symptom Manage. 2003;25:519–27.
Svendsen KB, Anersen S, Arnason S, et al. Breakthrough pain in malignant and non-malignant diseases: a review of prevalence, characteristics and mechanisms. Eur J Pain. 2005;9:195–206.
Goudas LC, Bloch R, Gialeli-Goudas M, et al. The epidemiology of cancer pain. Cancer Invest. 2005;23:182–90.
Fisch MJ, LKee JW, Weiss M, et al. Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol. 2012;30:1980–8.
Saunders CM. The management of terminal malignant disease. 1st ed. London: Edward Arnold; 1978.
Clinical practice guideline for the management of cancer pain – AHCPR archives. Clinical guideline number 9 AHCPR publication no. 94–0592: March 1994.
NCCN Guidelines Version 1.2014 Adult Cancer Pain.
Irani J, Fournier F, Bon D, et al. Patient tolerance of transrectal ultrasound-guided biopsy of the prostate. Br J Urol. 1997;79:608–10.
Bhomi KK, Lim HH, Consigliere DT, et al. Control of pain during transrectal ultrasound-guided prostate biopsy: a prospective study comparing two methods. Urol Int. 2007;79:332–5.
Gurbuz C, Canat L, Bayram G, et al. Visual pain score during transrectal ultrasound-guided prostate biopsy using no anaesthesia or three different types of local anaesthetic application. Scand J Urol Nephrol. 2010;44:212–6.
Seçkiner I, Haluk S, Erturhan S, Yagci F. A prospective, randomized control study comparing lidocaine and tramadol in periprostatic nerve blockage for transrectal ultrasound-guided prostate biopsy. Urology. 2011;78:257–60.
Skriapas K, Konstandinidis C, Samarinas M, et al. Pain level and anal discomfort during transrectal ultrasound for guided prostate biopsy. Does intrarectal administration of local anesthetic before periprostatic anesthesia makes any difference? Minerva Urol Nefrol. 2009;61:137–42.
Caliskan B, Mutlu N. Intrarectal ice application prior to transrectal prostate biopsy: a prospective randomized trial assessing pain and collateral effects. Int Braz J Urol. 2015;41:101–9.
Harper DM. Paracervical block diminishes cramping associated with cryosurgery. J Fam Pract. 1997;44(1):71–5.
Harper DM, Cobb JL. Cervical mucosal block effectively reduces the pain and cramping from cryosurgery. J Fam Pract. 1998;l47(4):285–9.
Harper DM. Pain and cramping associated with cryosurgery. J Fam Pract. 1994;39(6):551–7.
Sinaki M, Merritt JL, Stillwell GK. Tension myalgia of the pelvic floor. Mayo Clin Proc. 1977;52:717–22.
Boas RA, Schug SA, Acland RH. Perineal pain after rectal amputation: a 5-year follow-up. Pain. 1993;52:67.
Rigor BM. Pelvic cancer pain. J Surg Oncol. 2000;75:280–300.
Minsky BD, Cohen AM. Minimizing the toxicity of pelvic radiation therapy in rectal cancer. Oncology. 1988;2:28–9.
Mannaerts GH, Rutten HJ, Martijn H, et al. Effects on functional outcome after IORT-containing multimodality treatment for locally advanced primary and locally recurrent rectal cancer. Int J Radiat Oncol Biol Phys. 2002;54:1082–8.
Nader R, Rhines LD, Mendel E. Metastatic sacral tumors. Neurosurg Clin N Am. 2004;15:453–7.
Payer M. Neurological manifestation of sacral tumors. Neurosurg Focus. 2003;15:E1.
Graham GG, Scott KF. Mechanism of action of paracetamol. Am J Ther. 2005;12(1):46–55.
Chou R, McDonagh MS, Nakamoto E, Griffin J. Analgesics for osteoarthritis: an update of the 2006 comparative effectiveness review. Comparative effectiveness review No. 38. (Prepared by the Oregon Evidence-based Practice Center under Contract No. HHSA 290 2007 10057 I) AHRQ publication no. 11(12)-EHC076-EF. Rockville: Agency for Healthcare Research and Quality. October 2011. www.effectivehealthcare.ahrq.gov/reports/final.cfm.
Raffa RB, Buschman H, Christoph T, Eichenbaum G, Englberger W, Flores CM, et al. Mechanistic and functional differentiation of tapentadol and tramadol. Expert Opin Pharmacother. 2012;13(10):1437–49.
Pathan H, Williams J. Basic opioid pharmacology: an update. Br J Pain. 2012;6(1):11–6.
Quigley C, Joel S, Patel N, Baksh A, Sleven M. Plasma concentrations of morphine, morphine-6-glucuronide, and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer related pain. Palliat Med. 2003;17(2):185–90.
Hershman DL, Lacchetti C, Dworkin RH, Smith EML, Bleeker J, Cavaletti G, et al. Prevention and Management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology guideline. J Clin Oncol. 2014;32:1–30. doi:10.1200/JCO.2013.54.0914.
http://www.iasp-pain.org/Taxonomy#Pain. Accessed 3 Jan 2016.
Hardy J, Quinn S, Fazekas B, et al. Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain. J Clin Oncol. 2012;30:3611–7.
Nielson OS. Palliative radiotherapy of bone metastases: there is now evidence for the use of single fractions. Radiother Oncol. 1999;52:95.
Tong D, Gillick L, Hendrickson FR. The palliation of symptomatic osseous metastases: final results of the Study by the Radiation Therapy Oncology Group. Cancer. 1982;50:893–9.
Chow E, Harris K, Fan G, et al. Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol. 2007;25:1423–36.
Lutz S, Berk L, Chang E, et al. Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys. 2009;75:193.
Hird A, Chow E, Zhang L, et al. Determining the incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: results from three Canadian cancer centers. Int J Radiat Oncol Biol Phys. 2009;75(1):193–7.
Chow E, Meyer RM, Ding K, et al. Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind randomized placebo-controlled, phase 3 trial. Lancet Oncol. 2015;16:1463.
Finlay IG, Mason MD, Shelley M. Radioisotopes for the palliation of metastatic bone cancer: a systematic review. Lancet Oncol. 2005;6:392–400.
Mishra S, Bhatnagar S, Gupta D, Thulkar S. Anterior ultrasound-guided superior hypogastric plexus neurolysis in pelvic cancer pain. Anaesth Intensive Care. 2008;36(5):732–5.
Bhatnagar S, Gupta M. Evidence-based clinical practice guidelines for interventional pain management in cancer pain. Indian J Palliat Care. 2016;21(2):137–47.
Chambers WA. Nerve blocks in palliative care. Cr J Anesth. 2008;101(1):95–100.
Ahmed D, Mohamed M, Abd-Elbaky Mohamed S. Superior hypogastric plexus combined with ganglion impar neurolytic blocks for pelvic and/or perineal cancer pain relief. Pain Physician. 2014;18:E49–56.
Waldman SD. Atlas of interventional pain management. 4th ed. Philadelphia: Saunders Elsevier; 2014.
Kitoh T, Tanaka S, Ono K, Ohfusa Y, Ina H, Otagiri T. Combined neurolytic block of celiac, inferior mesenteric, and superior hypogastric plexuses for incapacitating abdominal and/or pelvic cancer pain. J Anesth. 2005;328–32.
Further Reading
Wilsey C, Ashford N, Dolin S. Presacral neurolytic block for relief of pain from pelvic cancer: description and use of a CT-guided lateral approach. Palliat Med. 2002;16(5):441–4.
Abrahm JL. A physician’s guide to pain and symptom management in cancer patients. 3rd ed. Baltimore: Johns Hopkins University Press; 2014.
Auret K, Schug SA. Pain management for the cancer patient – current practice and future developments. Best Pract Res Clin Anaesthesiol. 2013;27:545–61.
Dy SM, Asch SM, Naeim A, Sanati H, Walling A, Lorenz KA. Evidence-based standards for cancer pain management. J Clin Oncol. 2008;26(23):3879–85.
Jeffrey B. Halter, Joseph G. Ouslander, Mary E. Tinetti, Stephanie Studenski, Kevin P. High, Sanjay Asthana. Hazzard’s geriatirc medicine and gerontology, 6e.
Nersesyan H, Slavin KV. Current approach to cancer pain management: availability and implications of different treatment options. Ther Clin Risk Manag. 2007;3(3):381–400.
Portenoy RK. Treatment of cancer pain. Lancet. 2011;377(9784):2236–47.
Zhu YJ. Palliative radiotherapy for painful bone metastasis: short-course or long-course? Ann Palliat Med. 2012;1(1):78–80.
Rommens PM, Hessmann MH, editors. Intramedullary nailing: a comprehensive guide. London: Springer; 2015. doi:10.1007/978-1-4471-6612-2_31.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Hardy, S., Angelo, M., Haas, K., Sayed, H., Vanston, V.J. (2017). Cancer Pain in the Urogenital Region. In: Sabia, M., Sehdev, J., Bentley, W. (eds) Urogenital Pain. Springer, Cham. https://doi.org/10.1007/978-3-319-45794-9_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-45794-9_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-45792-5
Online ISBN: 978-3-319-45794-9
eBook Packages: MedicineMedicine (R0)